午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

CG-0009

CG-0009 Suppliers list
Company Name: TargetMol Chemicals Inc.
Tel:
Email: support@targetmol.com
Products Intro: Product Name:CG0009；CG 0009;CG-0009
CAS:944744-57-4
Package:100 mg；500 mg Remarks:REAGENT;FOR LABORATORY USE ONLY
Company Name: TargetMol Chemicals Inc.
Tel: +8613564774135
Email: zijue.cai@tsbiochem.com
Products Intro: Product Name:CG0009
CAS:944744-57-4
Package:50mg;2180USD|100mg;2800USD|25mg;1670USD
Company Name: TargetMol Chemicals Inc.  
Tel: 15002134094
Email: marketing@targetmol.cn
Products Intro: Product Name:CG0009
CAS:944744-57-4
Package:50mg/RMB 15300;100mg/RMB 19500;25mg/RMB 11700

CG-0009 manufacturers

  • CG0009
  • CG0009 pictures
  • $2180.00 / 50mg
  • 2024-10-28
  • CAS:944744-57-4
  • Min. Order:
  • Purity:
  • Supply Ability: 10g
CG-0009 Basic information
Product Name:CG-0009
Synonyms:CG 0009;CG0009;CG-0009
CAS:944744-57-4
MF:C26H31N7O
MW:457.58
EINECS:
Product Categories:
Mol File:944744-57-4.mol
CG-0009 Structure
CG-0009 Chemical Properties
Safety Information
MSDS Information
CG-0009 Usage And Synthesis
DescriptionCG0009 is a potent and selective a Glycogen Synthase Kinase 3 (GSK3) inhibitor. CG0009, inhibits proliferation, induces apoptosis cell death, and activates the p53-Bax pathway in breast cancer cells, predominantly via cyclin D1 depletion. CG0009 induces significant growth inhibition and cell death in breast cancer cell lines, with a wide range of IC50 values (between 0.49 (MCF7) and 11 μM (NCI/ADR-RES and BT549)). CG0009 inhibits breast cancer cell growth through cyclin D1 depletion and p53 activation, and may thus offer an innovative therapeutic approach for breast cancers resistant to hormone-based therapy.
CG-0009 Preparation Products And Raw materials
Tag:CG-0009(944744-57-4) Related Product Information